Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  fluorine F 18 sodium fluoride
Find trials that include:  Any drugs shown
Results 1-6 of 6 for your search:
Start Over
F18PET/CT Versus TC-MDP Scanning to Detect Bone Mets
Phase: Phase III
Type: Diagnostic
Age: 18 and over
Trial IDs: AMI-2008-01, NCI-2014-02587, NCT00882609
A Study of DKN-01 and Lenalidomide/Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 30 and over
Trial IDs: DEK-DKK1-P101, NCI-2014-00197, DKN-01, LY2812176, NCT01711671
Cabozantinib-S-Malate in Treating Patients with Metastatic Bladder Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 12-C-0205, NCI-2013-01555, 120205, 12-C-0205J, P11900, 9236, NCT01688999
Fluorine F 18 Sodium Fluoride PET/CT and Whole Body and Axial MRI in Finding Metastases in Patients with Recurrent Prostate Cancer
Phase: Phase II
Type: Diagnostic
Age: 18 and over
Trial IDs: 13365, NCI-2013-01924, 114288, NCT01967862
Fluorine F 18 Sodium Fluoride and Fludeoxyglucose F 18 Combined Positron Emission Tomography/Computed Tomography Scan in Diagnosing Patients With Skeletal Neoplasms
Phase: No phase specified
Type: Diagnostic
Age: Over 18
Trial IDs: VAR0024, NCI-2011-00804, 9434, 98043, NCT00725387
FDG PET/MRI and NaF PET/CT in Predicting Response to Sipuleucel-T Treatment in Patients with Metastatic Castration Resistant Prostate Cancer
Phase: No phase specified
Type: Diagnostic
Age: 18 and over
Trial IDs: NYU S12-03902, NCI-2014-00053, i12-03902, NCT02042053
Start Over